Form 4: Amneal Pharmaceuticals Director Gautam Patel Reports Stock Unit Vesting
SEC Form 4 Filing
Director Gautam Patel reports vesting of restricted stock units and acquisition of Class A Common Stock in Amneal Pharmaceuticals.
Summary
- On May 10, 2024, Gautam Patel, a director of Amneal Pharmaceuticals, had 76,453 restricted stock units vest.
- These units converted into 76,453 shares of Class A Common Stock.
- Following the transaction, Patel directly owns 2,048,886 shares of Class A Common Stock.
Sentiment
Score: 5
Explanation: This is a routine disclosure of stock unit vesting, neither particularly positive nor negative.
Industry Context
Form 4 filings are standard disclosures required by the SEC when insiders, like directors and officers, transact in their company's stock. This provides transparency to the market.
Key Dates
| Date | Description |
|---|---|
| 05/09/2023 | Reporting person was granted 76,453 restricted stock units vesting on May 10, 2024 |
| 05/10/2024 | Transaction Date: Restricted stock units vested and converted to Class A Common Stock |
| 05/14/2024 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.